Jain Annish, Singh Sumit K, Arya Shailendra K, Kundu Subhas C, Kapoor Sonia
Department of Biotechnology, University Institute of Engineering and Technology, Panjab University, Chandigarh 160 014, India.
3B's Research Group, I3Bs - Biomaterials, Biodegradables and Biomimetics, University of Minho, AvePark, 4805-017 Barco, Guimarães, Portugal.
ACS Biomater Sci Eng. 2018 Dec 10;4(12):3939-3961. doi: 10.1021/acsbiomaterials.8b01098. Epub 2018 Nov 15.
The development of drug delivery systems using nanoparticles as carriers for small and large therapeutic molecules remains a rapidly growing area of research. The advantages of using proteins to prepare nanoparticles for drug delivery applications include their abundance in natural sources, biocompatibility, biodegradability, easy synthesis process, and cost-effectiveness. In contrast to several particulate systems like nanoparticles from metallic and inorganic/synthetic sources, the protein nanoparticles do not have limitations such as potential toxicity, large size, accumulation, or rapid clearance from the body. In addition, protein-based nanoparticles offer the opportunity for surface modification by conjugation of other protein and carbohydrate ligands. This enables targeted delivery to the desired tissue and organ, which further reduces systemic toxicity. The use of protein nanoparticles for such applications could therefore prove to be a better alternative to maneuver and improve the pharmacokinetic and pharmacodynamic properties of the various types of drug molecules. In this review, while focusing on the properties of a few proteins such as the silk protein fibroin, we attempt to provide an overview of the existing protein-based nanoparticles. We discuss various methods for the synthesis of this class of nanoparticles. The review brings forth some of the factors that are important for the design of this class of nanoparticles and highlights the applications of the nanoparticles obtained from these proteins.
使用纳米颗粒作为小分子和大分子治疗药物载体的药物递送系统的开发仍然是一个快速发展的研究领域。利用蛋白质制备用于药物递送应用的纳米颗粒的优点包括其在天然来源中含量丰富、生物相容性好、可生物降解、合成过程简单以及成本效益高。与来自金属和无机/合成来源的纳米颗粒等几种颗粒系统不同,蛋白质纳米颗粒不存在潜在毒性、尺寸大、蓄积或从体内快速清除等局限性。此外,基于蛋白质的纳米颗粒提供了通过与其他蛋白质和碳水化合物配体共轭进行表面修饰的机会。这使得能够靶向递送至所需的组织和器官,从而进一步降低全身毒性。因此,将蛋白质纳米颗粒用于此类应用可能被证明是一种更好的选择,可用于调控和改善各类药物分子的药代动力学和药效学性质。在本综述中,我们在聚焦于一些蛋白质(如丝蛋白纤维蛋白)的特性的同时,试图对现有的基于蛋白质的纳米颗粒进行概述。我们讨论了合成这类纳米颗粒的各种方法。该综述提出了一些对这类纳米颗粒设计很重要的因素,并突出了由这些蛋白质获得的纳米颗粒的应用。